Cure My Disease

Don't miss your cure!

 Log in / Sign up

Prospective evaluation of temporal clinical dynamics, physiologic trajectories, and Time-Dependent digital biomarkers for prediction of clinically meaningful patient outcomes

NCT ID NCT07812831

NEW Sponsor: Truway Health, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 10, 2026 · Last updated Sep 10, 2026

Summary

TH-CLINICAL-TIME is a prospective, longitudinal observational study evaluating how changes in clinical measurements over time may help researchers better understand patient health trajectories and clinically meaningful outcomes. The study will examine patterns such as changes from an individual's baseline, rate of change, persistence of abnormalities, variability, recurrence, and recovery following clinical events. Data may include routinely collected clinical measurements, physiologic observations, laboratory results, cardiac measurements, imaging-derived measurements, patient-reported information, and remote or digital health data when available and permitted by the study protocol. The study will investigate whether these temporal patterns provide additional information beyond individual measurements taken at a single point in time. The planned study horizon extends from 2026 through 2076, while individual participant follow-up will occur according to the approved study schedule, consent, and applicable requirements.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2026

Expected to finish

Sep 2076

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population will consist of adults aged 18 years and older, including individuals with and without established medical conditions. Participants will be followed longitudinally to characterize individualized clinical trajectories and temporal dynamics using available clinical, physiologic, laboratory, imaging-derived, patient-reported, and remote or digital health information as permitted by the protocol. The population is intended to support evaluation of temporal biomarkers, longitudinal patterns, clinical trajectory features, and time-dependent associations with clinically meaningful outcomes.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 years or older. * Able and willing to provide informed consent, when informed consent is required by the approved study protocol and applicable regulations. * Willing and able to participate in longitudinal collection or evaluation of clinical, physiologic, laboratory, imaging-derived, patient-reported, or remote/digital health information as applicable to the study protocol. * Ability to complete the protocol-defined follow-up schedule or provide sufficient longitudinal observations for analysis. * Individuals with or without established medical conditions may be eligible, provided their participation is consistent with the study protocol. * Availability of sufficient baseline information or measurements to establish an individualized reference state when required for the applicable analysis. Exclusion Criteria: * Inability to provide informed consent when consent is required and no legally authorized representative process is applicable. * Inability to comply with protocol-defined data collection or follow-up requirements. * Circumstances that, in the judgment of the investigator, would prevent reliable longitudinal data collection or interpretation. * Enrollment in another research protocol that would materially interfere with participation or interpretation of the outcomes, when applicable. * Any other exclusion criterion specifically identified in the IRB/ethics-approved protocol.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Biomarkers are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Sexual Behavior substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Biomarkers Cardio-pulmonary Clinical outcomes Drugs of abuse Epidemic disease Health risks Longitudinal studies Pandemic Population Population groups Predictive value of tests Prospective studies Sex behavior Sex characteristics Sex hormone Surgical Telemedicine Time efficiency Time management Time of death Time perception Time reaction

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Truway Health, Inc.

    New York, New York, 10016, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.